Page 7 - Research Developments News Today

El catedrático de Ingeniería Química de la Universidad Pública de Navarra (UPNA) Antonio Gil Bravo es el...

/PRNewswire/ -- Nayax Ltd. (TASE: NYAX), a global commerce enablement and payments platform designed to help merchants scale their business, today reported...

AuntMinnies RADCast@ISMRM offers exclusive coverage of ISMRM 2021 online conference Share Article The ISMRMs mission to educate the MRI community continues with this years virtual meeting. Although this will hopefully be the last fully virtual meeting, there are unparalleled and interactive opportunities for sharing research, learning, and networking at this year’s meeting. ARLINGTON, Va. (PRWEB) May 15, 2021 For the third strai...

Following the completion of the spin-off of the Upjohn Business (4) in the fourth quarter of 2020, Pfizer now operates as a focused innovative biopharmaceutical company engaged in the discovery, development, manufacturing, marketing, sales and distribution of biopharmaceutical products worldwide. Revenues and expenses associated with the Upjohn Business (4) for first-quarter 2020 have been recategorized as discontinued operations and excluded from Adjusted (2) results. Pfizer’s Meridian subsi...

Apr 15, 2021 Aligarh: Dr Musavvir Ali, Assistant Professor, Department of Mathematics, Aligarh Muslim University (AMU) delivered a talk on ‘Mathematics of Spacetime and Recent Research Developments on the Spacetime Geometry’ in the ‘National Science Day’ programme of the Chitkara University, Rajpura, Punjab. He delivered the invited talk as the Chief Guest. Share

5% Below are specific updates on pipeline assets since our previous earnings announcement on October 27, 2020: Abrocitinib (PF-04965842) — In November 2020, Pfizer announced positive top-line results from the fifth Phase 3 trial of abrocitinib, JADE REGIMEN, a 52-week study which investigated abrocitinib in patients 12 and older with moderate to severe atopic dermatitis (AD) following response to initial open label induction treatment with abrocitinib 200 mg. Patients were randomized into on...

American lung association. >> you can believe that the number one killer of women is lung cancer. i came on with a specific mission which was to share the word, share my voice. im inviting people to share theirs. go on lung force.org and the most wonderful thing that cbs has done where you can go to anyone at any time day or night to any register and make a donation. it is stoppable early. there is many, many resources and many research developments and we dont have enough money for it. >> but w...